Results 41 to 50 of about 8,550,874 (267)

Carcinomas and Carcinoid Tumors of the Lungs and Bronchi in Children and Adolescents: The EXPeRT Recommendations

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Primary lung carcinomas and bronchial carcinoid tumors (BC) are very rare malignancies in childhood. While typical BC and mucoepidermoid carcinomas are mostly low‐grade, localized tumors with a more favorable prognosis than in adults, necessitating avoidance of overtreatment, adenocarcinomas of the lung are often diagnosed at advanced disease ...
Michael Abele   +19 more
wiley   +1 more source

Noty o autorach

open access: yesImages, 2020
Noty o ...
Redakcja Images
doaj  

Introduction

open access: yesImages, 2023
This issue of “Images” is entitled Ukraine in Flames, echoing the English-language adaptation of a renowned cinematic creation byUkrainian director Oleksandr Dovzhenko (1894–1956).
Redakcja Images
doaj  

Exploring Preferences for a Digital Single‐Session Intervention for Adolescent Siblings of Youth With Cancer

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Introduction Adolescent siblings of children with cancer are at elevated risk for psychosocial problems. Unfortunately, various barriers such as limited family time and resources, conflicting schedules, and psychosocial staffing constraints at cancer centers hinder sibling access to support.
Christina M. Amaro   +10 more
wiley   +1 more source

European Standard Clinical Practice Guideline and EXPeRT Recommendations for the Diagnosis and Management of Gastroenteropancreatic Neuroendocrine Neoplasms in Children and Adolescents

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Pediatric gastroenteropancreatic neuroendocrine neoplasms (GEP‐NENs) are extremely rare and clinically heterogeneous. Management has largely been extrapolated from adult practice. This European Standard Clinical Practice Guideline (ESCP), developed by the EXPeRT network in collaboration with adult NEN experts, provides (adult) evidence ...
Michaela Kuhlen   +23 more
wiley   +1 more source

Moving Digital Images [PDF]

open access: yes, 2014
For over six years the Marquette University Archives managed patron-driven scanning requests using a desktop version of Extensis Portfolio while building thematically-based digital collections online using CONTENTdm.
Sweetser, Michelle
core   +1 more source

Can a 3D Virtual Imaging Model Predict Eagle Syndrome?

open access: yesApplied Sciences, 2022
Eagle Syndrome is an underestimated syndrome with broad and often unspecific signs and symptoms. Both the neuropathic and vascular patterns need a thorough investigation in terms of all their clinical and radiological aspects.
Enrico Nastro Siniscalchi   +7 more
doaj   +1 more source

Efficacy and Tolerability of Topotecan/Cyclophosphamide/Dinutuximab in Relapsed and Refractory High‐Risk Neuroblastoma: A Multi‐Institutional Retrospective Study

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Purpose Chemoimmunotherapy with irinotecan, temozolomide, and dinutuximab (I/T/DIN) has emerged as first‐line therapy for relapsed/refractory (r/r) high‐risk neuroblastoma (HRNB) in North America. Topotecan and cyclophosphamide (T/C) are often used in combination with dinutuximab in the setting of lack of response, progression, or incomplete ...
Benjamin J. Lerman   +17 more
wiley   +1 more source

Stitching IC Images [PDF]

open access: yes, 2002
Image stitching software is used in many areas such as photogrammetry, biomedical imaging, and even amateur digital photography. However, these algorithms require relatively large image overlap, and for this reason they cannot be used to stitch the ...
Keyes, Edward, Piché, Robert
core  

Clinical Course and Impact of Breaks in Therapy for Children With Relapsed/Refractory Solid Tumors

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Introduction Pediatric relapsed or refractory (R/R) solid tumors carry a dismal prognosis, and postrelapse patient experiences are not well described. We present postrelapse outcomes, including number of R/R events and subsequent therapy regimens.
Matthew T. McEvoy   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy